NCT06058377 2026-04-16
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
7 trialsNCT06632977 2026-04-07
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT07091617 2026-04-07
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT04475640 2026-04-02
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Phase NA Recruiting
NCT04354675 2026-03-31
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT07498829 2026-03-27
PROTECT-C
Queen Mary University of London
Phase NA Recruiting
NCT03233191 2026-03-23
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting